EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Epithelial Regnase-1 inhibits colorectal tumor growth by regulating IL-17 signaling via degradation of NFKBIZ mRNA

Eriko Iguchi, Atsushi Takai iD, Natsumi Oe, Yosuke Fujii iD, Mayuki Omatsu, Haruhiko Takeda, Takahiro Shimizu, Takahisa Maruno, Yuki Nakanishi, Masanori Yoshinaga iD, Takashi Maruyama, Hiroyuki Marusawa und 3 weitere

Proceedings of the National Academy of Sciences · 10.06.2025 · 122 (23)

DOI: 10.1073/pnas.2500820122 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Proceedings of the National Academy of Sciences, online erschienen am 03.06.2025. Verfasst von Eriko Iguchi und 14 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastroenterology and Hepatology, Graduate School of Medicine, Kyoto University, Kyoto 606-8507, Japan. Hauptthemen laut MEDLINE: Interleukin-17, Ribonucleases, Colorectal Neoplasms, Transcription Factors. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 62 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: MEXT | Japan Society for the Promotion of Science (JSPS), Japan Agency for Medical Research and Development (AMED), MEXT | JST | Moonshot Research and Development Program (Moonshot).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Regnase-1 is a ribonuclease that regulates inflammation in immune cells by degrading cytokine mRNA. Regnase-1 was identified as one of the frequently mutated genes in the inflamed colorectal epithelium of patients with ulcerative colitis; however, its significance in intestinal epithelial cells during the tumorigenic process remains unknown. Therefore, we developed an Apc Min/+ mouse model lacking Regnase-1 in intestinal epithelia. Regnase-1 deletion significantly enhanced colon tumor growth accompanied by elevated levels of extracellular signal-regulated kinase (ERK) phosphorylation in tumor tissues. Transcriptome analysis of the tumor tissues revealed that Nfkbiz , a mediator of the interleukin (IL)-17 signaling pathway, was the primary degradative target of Regnase-1 in enterocytes and that Regnase-1 deficiency enhanced IL-17 signaling. The treatment with antibiotics or IL-17-neutralizing antibody canceled the proliferative effect of colon tumors due to Regnase-1 deletion, suggesting the protective role of Regnase-1 against colon tumor growth was dependent on IL-17 signaling triggered by gut microbes. Analysis of the Nfkbiz knockout mouse model demonstrated that the tumor-suppressive effect of Regnase-1 depended on Nfkbiz expression. Remarkably, oral treatment of dimethyl fumarate, a potential inhibitor of Regnase-1 protein inactivation, suppressed tumor growth, downregulated Nfkbiz , and suppressed ERK activation. Furthermore, TCGA data analysis revealed that low Regnase-1 expression in colorectal cancer tissue was related to poor prognosis. Therefore, Regnase-1 represses colon tumor growth by regulating IL-17 signaling via Nfkbiz mRNA degradation. Regnase-1 could be a potential therapeutic target in colon tumors.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Interleukin-17RibonucleasesColorectal NeoplasmsTranscription FactorsAnimalsMiceSignal TransductionHumansRNA, MessengerRNA StabilityMice, KnockoutIntestinal MucosaGene Expression Regulation, NeoplasticCell ProliferationMice, Inbred C57BLAdaptor Proteins, Signal Transducing

Stichwörter der Autor:innen

IL-17Regnase-1colorectal cancer

Substanzen

Interleukin-17RibonucleasesRNA, MessengerNfkbiz protein, mouseTranscription FactorsZc3h12a protein, mouseAdaptor Proteins, Signal Transducing

Autor:innen und Institutionen

  • Department of Gastroenterology and Hepatology, Graduate School of Medicine, Kyoto University, Kyoto 606-8507, Japan.
  • Department of Medical Chemistry, Graduate School of Medicine, Kyoto University, Kyoto 606-8501, Japan.
  • Mucosal Immunology Unit, National Institute of Dental and Craniofacial Research, National Institute of Health, Bethesda, MD 20892.
  • Department of Gastroenterology and Hepatology, Osaka Red Cross Hospital, Osaka 543-8555, Japan.
  • Department of Surgery, Graduate School of Medicine, Kyoto University, Kyoto 606-8507, Japan.

ORCID-Profile: Atsushi Takai, Yosuke Fujii, Masanori Yoshinaga, Osamu Takeuchi

Förderung

  • MEXT | Japan Society for the Promotion of Science (JSPS)
  • Japan Agency for Medical Research and Development (AMED)
  • MEXT | JST | Moonshot Research and Development Program (Moonshot)
  • MEXT | JST | Co-creation place formation support program (COI-NEXT)

Zitieren

APA

Iguchi, E., Takai, A., Oe, N., Fujii, Y., Omatsu, M., Takeda, H., Shimizu, T., Maruno, T., Nakanishi, Y., Yoshinaga, M., Maruyama, T., Marusawa, H., Obama, K., Takeuchi, O., & Seno, H. (2025). Epithelial Regnase-1 inhibits colorectal tumor growth by regulating IL-17 signaling via degradation of NFKBIZ mRNA. Proceedings of the National Academy of Sciences, 122(23). https://doi.org/10.1073/pnas.2500820122

Vancouver

Iguchi E, Takai A, Oe N, Fujii Y, Omatsu M, Takeda H, et al. Epithelial Regnase-1 inhibits colorectal tumor growth by regulating IL-17 signaling via degradation of NFKBIZ mRNA. Proceedings of the National Academy of Sciences. 2025;122(23). doi:10.1073/pnas.2500820122

BibTeX
@article{Iguchi2025,
  author = {Iguchi, Eriko and Takai, Atsushi and Oe, Natsumi and Fujii, Yosuke and Omatsu, Mayuki and Takeda, Haruhiko and Shimizu, Takahiro and Maruno, Takahisa and Nakanishi, Yuki and Yoshinaga, Masanori and Maruyama, Takashi and Marusawa, Hiroyuki and Obama, Kazutaka and Takeuchi, Osamu and Seno, Hiroshi},
  title = {Epithelial Regnase-1 inhibits colorectal tumor growth by regulating IL-17 signaling via degradation of NFKBIZ mRNA},
  journal = {Proceedings of the National Academy of Sciences},
  year = {2025},
  volume = {122},
  number = {23},
  doi = {10.1073/pnas.2500820122}
}
Kostenlos starten →